Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma - Related Studies

Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma

This study has been completed.

Study NCT00019890. Last updated on March 2, 2007. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Stage IV Melanoma
		Stage III Melanoma
		Recurrent Melanoma

2	Additional conditions recognized in this trial
		Melanoma

3	More general conditions related to this trial
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Nerve Tissue
		Neuroectodermal Tumors
		Neuroendocrine Tumors
		Nevi and Melanomas

4	Interventions listed in this trial
		sargramostim

5	Sponsors listed in this trial
		National Cancer Institute (NCI)